The long-term efficacy of eltrombopag in children with immune thrombocytopenia
The long-term efficacy of eltrombopag in children with immune thrombocytopenia
About this item
Full title
Author / Creator
Yang, Li , Sang, Bao-Hua , Yang, Chun-Hui , Xiao, Zu-Gang , Fang, Chun-Lian , Lv, Yu , Li, Na , Yang, Qing , Chai, Shu-Min , Tian, Xin , Zhang, Xian-Wen and Huang, Ti-Long
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Immune thrombocytopenia (ITP) is the most common autoimmune disorder characterized by decreased platelet counts and impaired platelet production. Eltrombopag has been demonstrated to be safe and effective for children with ITP. It is reported eltrombopag can achieve a sustained response off treatment. However, data on its overall efficacy and safet...
Alternative Titles
Full title
The long-term efficacy of eltrombopag in children with immune thrombocytopenia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3072001183
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3072001183
Other Identifiers
ISSN
0939-5555,1432-0584
E-ISSN
1432-0584
DOI
10.1007/s00277-024-05857-y
